Alumis revenue was $8.40M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $1.7M, down 9.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ALMS annual revenue was $24.1M, with Infinity% growth year-over-year.
ALMS past revenue growth
How has ALMS's revenue growth performed historically?
On Invalid Date, Alumis (NASDAQ: ALMS) reported Q1 2026 revenue of $1.74 million up 89.99% year over year. In the same quarter last year, Alumis's revenue was $17.39 million.
What was Alumis's revenue in 2025?
Alumis's annual revenue for the twelve months ending Dec 31, 2025 was $24.05 million, a Infinity% increase year over year.
How much does Alumis make in a day?
Based on Alumis annual revenue for the past three years, ALMS makes an average of $21,963.47 per day.
What was Alumis's annual revenue growth in the past year?
As of Q2 2026, Alumis's revenue has grown -51.68% year over year. This is 293.88 percentage points lower than the US Biotechnology industry revenue growth rate of 242.2%. Alumis's revenue in the past year totaled $8.40 million.
How much does Alumis make in a year?
Alumis's revenue by year for the past three years is:
Alumis's revenue for the twelve months ending Dec 31, 2025 was $24.05 million, a Infinity% increase year over year.
Alumis's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
Alumis's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.